This study was intended to evaluate the performance of biparametric MRI (bpMRI) radiomics for detecting clinically significant prostate cancer (csPCa) in men with prostate-specific antigen (PSA) of 4–10 ng/mL. This evidence concerns the gene KLK3 and Familial prostate cancer.